Our results show that TGF-β1-induced fibrogenesis may be an intracellular metabolic disorder characterised by increased intracellular ribosomal proteins and dysregulation of proteins involved in multiple other metabolic pathways (Figs. 3 and 4). The gene discussed is TGFB1; the disease is metabolic disease.